Gedela_Srinubabu

Gedela Srinubabu

Gedela Srinubabu

Scientist, industrialist


Gedela Srinubabu is the chief executive officer of Pulsus Group.[3] He founded the OMICS Publishing Group publishing group, scientific journal publishing company that publishes science findings online for free.[4]

Quick Facts Born, Alma mater ...

Srinubabu served as the co-convenor of the Health, Pharma, and Tech Summit Series, executed across G20 countries to promote AI in healthcare and technology advancements.[5][6] He is also serving as BC Leader, participated in farmer empowerment programs and also serving as executive council member of Dr Ambedkar University. [7][8][9]

However, OMICS journals and other journals, conferences have been characterized as predatory publishing journals and predatory conferences with poor quality controls and a lack of legitimate services[10][11][12] As a result of this business model, Srinubabu's journals have been banned from indexing within the National Institutes of Health's PubMed Central.[13] Additionally, in 2019, his company OMICS Publishing Group[14] was required to pay 50.1 million dollars in damages[15] following a US Federal Trade Commission complaint that the company was deceiving researchers[16] and the academicians.[17][18]

Biography

Srinubabu completed his PhD from Andhra University and his post-doctorate from Stanford University. In 2007, he received the Young Scientist Award from the Human Proteome Organization in Seoul, South Korea.[19][13][20]

Srinubabu has published research articles on how to study biological phenomena using mathematical models and how to detect cancer or diabetes early. He has published about 30 articles in various peer-reviewed journals. According to Google Scholar, Srinubabu's articles have been cited about 580 times, giving him an h-index of 13.[21]

Scientific publishing

Srinubabu founded the notorious open-access publisher, OMICS Publishing Group, widely regarded as predatory. He purchased Pulsus Group in 2016, causing controversy and putting the future of the journals that it published into question.[12] The company has been placed on Jeffrey Beall's list of "Potential, possible, or probable" predatory open-access publishers.[22]

FABA Vice-President

Gedela Srinubabu as FABA Vice President for China-India Bilateral

In 2013, Srinubabu served as the Vice President of the Federation of Asian Biotech Association (FABA) to improve the global trade, BS Bajaj said that the representation and services of Gedela is crucial in increasing FABA's global growth.[1][23] In 2019, Srinubabu worked for Bilateral investment treaty of India and China.[24][25]

Europe-India trade delegation

Belgium Embassy delegates and European delegation team visited the Pulsus Group office in Hyderabad in 2018 to sign an agreement to establish a Pulsus center in Belgium.[26] At the 2019 Thessaloniki International Fair (TIF) held in Greece, Srinubabu along with Indian Union Minister Hardeep Singh Puri participated as Indian delegation and met with the Prime Minister of Greece, Kyriakos Mitsotakis to discuss the translation of health care and agriculture information into regional languages.[2][27][28]

Gedela Srinubabu - Indo American Chamber of Commerce 2022

Since 2013, US-based blogger Jeffrey Beall has used his personal blog, scholarlyoa.com, to criticise the publishing practises of Omics Group and Srinubabu. Through his blog, allegations were made against Omics regarding the quality of its scientific journals and its business practises.[29][30] Omics files a lawsuit against Jeffrey Beall, seeking damages of $1 billion.[31] Effective January 2017, Jeffrey Beall resigned from his services at University of Colorado Denver and shut his blogs. However, no further follow-up was made about damages of $1 billion in legal affairs.[32]

In 2016, based on blog postings by Beall, the Trade Commission of the United States filed a lawsuit against Omics publishing practices, citing their detrimental effects on American publisher's loss of trade to the United States. If 10,000 articles article is published in open access journals, the publication cost is about $10 million with an average $2000 article processing cost, depending on the open-access journal publisher's model, and if the same 10,000 articles are published under a subscription business, they can generate about $500 million annually by giving subscriptions to thousands of universities and research institutions across the world. Subscription models are followed by the majority of Western publishing companies, including academic publishing companies of United States.[33][34] In April 2019, the court imposed a fine of US$50.1 Million on Omics companies.[35][36][37] Omics' lawyer said that this was an unfair allegation and that Omics had sued the US Federal Trade Commission for $3.11 billion in damages, saying it had caused loss of revenue and reputation.[36][38] Srinubabu commented on the case filed by the Federal Trade Commission. "The Federal Trade Commission's allegation is completely wrong... They don't know what a journal is. Don't know what peer review is. They are illiterate in this matter. But scientists are not illiterate, they know which article to publish in which journal."[38]

In politics

The party announced Srinubabu as the Jana Sena candidate for the Visakhapatnam parliamentary constituency in the 2019 general elections [39] But after two or three days, Srinubabu left the party and joined the YSR Congress party.[40]

Philanthropic activities

In 2018 Srinubabu visited areas affected by Cyclone Titli and observed distribution of food, blankets and clothing.[41][42][43] His organization has donated one crore rupees to Government of Andhra Pradesh, twenty five lakh rupees to Government of Telangana and distributed masks and sanitizers in various districts for the relief of coronavirus during the COVID-19 pandemic in India,[44][45] and also donated Rs 20 lakhs to Ram Mandir construction.[46]

Awards

Dr Srinubabu Gedela Champions of Change Award from Vice President of India

Srinubabu received the Pride of the Nation Award in 2019,[47] and the Government of India Champions of Change 2018 award.[48]

Andhra Premier League Vizag Warriors

Srinubabu is the owner of Vizag Warriors, of the Andhra Premier League T20 cricket league in Andhra Pradesh.[49][50][51]

Indian actor, producer and businessman Ram Charan has invested in the team with Srinubabu, aiming to get the team promoted to the IPL in 2024.[52][53]


References

  1. "Asian biotech body Vice-President". thehindubusinessline.com. 14 October 2013.
  2. "'India will become AI -Powered manufacturing hub'". The Times of India. 8 November 2023. Retrieved 15 December 2023.
  3. Bureau, The Hindu (16 December 2022). "Global Tech team to promote the G20-Summit from January". The Hindu. Retrieved 15 December 2023.
  4. Patnaik, Santosh (26 September 2012). "Chanting success mantra, scientific way". The Hindu. Archived from the original on 12 April 2021. Retrieved 30 October 2019.{{cite news}}: CS1 maint: bot: original URL status unknown (link)
  5. Deprez, Esmé E.; Chen, Caroline (29 August 2017). "Medical Journals Have a Fake News Problem". Bloomberg News. Archived from the original on 25 January 2019.
  6. Roberts, William Clifford (1 February 2018). "Facts and ideas from anywhere". Baylor University. Vol. 31, no. 1. pp. 141–151. doi:10.1080/08998280.2017.1401850. PMC 5903519. PMID 29686586.
  7. "FTC Charges Academic Journal Publisher OMICS Group Deceived Researchers". Federal Trade Commission. 26 August 2016. Retrieved 11 October 2023.
  8. Prasad, R. (3 April 2019). "Hyderabad-based OMICS fined $50 million for 'unfair, deceptive business practices'". The Hindu. ISSN 0971-751X. Retrieved 11 October 2023.
  9. "US court fines journal publisher USD 50 million for 'deceptive practices'". The Indian Express. 5 April 2019. Retrieved 11 October 2023.
  10. "Cases and Proceedings - OMICS Group Inc". Federal Trade Commission. 26 August 2016.
  11. Patnaik, Santosh (26 September 2012). "Chanting success mantra, scientific way". The Hindu. Archived from the original on 12 April 2021. Retrieved 30 October 2019.
  12. Beall, Jeffrey. "LIST OF PUBLISHERS". Scholarly Open Access. Archived from the original on 17 September 2016. Retrieved 21 September 2016.
  13. "Srinubabu Gedela is FABA vice president". www.biospectrumasia.com. 13 October 2013.
  14. "Pulsus to expand scientific research, publications to Europe". economictimes.indiatimes.com. 25 April 2018.
  15. Beall, Jeffrey; Levine, Richard (25 January 2013). "OMICS Goes from "Predatory Publishing" to "Predatory Meetings"". Scholarly Open Access. Archived from the original on 5 June 2016. Retrieved 22 October 2016.
  16. "The OMICS Publishing Group's Empire is Expanding". scholarlyoa.co. 22 July 2013. Archived from the original on 19 October 2023. Retrieved 21 May 2023.
  17. "Publishing firm in $1 bn libel row with US blogger". www.hindustantimes.com. 18 May 2013.
  18. "OMICS Group Inc". ఫెడరల్ ట్రేడ్ కమిషను. 26 August 2016. Archived from the original on 23 March 2022. Retrieved 23 March 2022.
  19. Prasad, R. (3 April 2019). "Hyderabad-based OMICS fined $50 million for 'unfair, deceptive business practices'". The Hindu. ISSN 0971-751X. Archived from the original on 23 March 2022. Retrieved 23 March 2022.
  20. "BRIEF OF THE FEDERAL TRADE COMMISSION" (PDF). www.ftc.gov. 11 October 2011. Archived from the original (PDF) on 4 November 2021. Retrieved 4 November 2021.
  21. Yadav, Shamlal (20 July 2018). "OMICS chief Srinubabu Gedela: 'Our revenue from India is almost zero'". The Indian Express.
  22. "32 మంది అభ్యర్థులతో జనసేన తొలి జాబితా!". andhrapradesh.suryaa.com. Archived from the original on 23 March 2022. Retrieved 23 March 2022.
  23. "జనసేనకు మరో షాక్". ఆంధ్రజ్యోతి. 16 March 2019. Archived from the original on 23 March 2022. Retrieved 23 March 2022.
  24. "Ram Charan: Ram Charan is buying a cricket team.. not in IPL!". theglobalfrontier.com. 6 May 2023. Retrieved 13 May 2023.

Share this article:

This article uses material from the Wikipedia article Gedela_Srinubabu, and is written by contributors. Text is available under a CC BY-SA 4.0 International License; additional terms may apply. Images, videos and audio are available under their respective licenses.